 |
|
|
 |
FDA Clears Camera Pill To Photograph Small Intestine
FDA today cleared for marketing a swallowable capsule containing a tiny camera that snaps pictures twice a second as it glides through the small intestine. The product represents a technological advance in methods of examining the gastrointestinal tract. more
|
|
To Help Women Reduce Their Concerns About Gaining Weight Found To Be Effective In Helping Them To Stop Smoking
Researchers at the University of Pittsburgh School of Medicine found that a treatment program that focuses on reducing women's concerns about weight is the first treatment to significantly improve smoking cessation in weight-concerned women. Previous interventions for weight-concerned women assumed that the best approach to fostering smoking cessation was to help them prevent any weight gain after they quit smoking. This study, as well as other research, indicates that this assumption is not correct, and that directly reducing the concerns about weight, rather than the weight gain itself, is what will help these women quit smoking. more
|
|
|
|
Blueprint For Action On Breast Feeding
Recognizing the considerable scientific evidence that states breastfeeding is one of the most important contributors to infant health, the Office on Women's Health within the U.S. Department of Health and Human Services (OWH) and the American Association of Health Plans (AAHP) today released a special monograph to highlight programs and practices in health plans that are successfully promoting breastfeeding among new mothers. more
|
|
Advanced Cholesterol Sub-Fraction Test Cleared By The FDA--Test Approved Just As The NCEP Recommends More Cholesterol Drug Therapy
The Food & Drug Administration (FDA) has cleared Quantimetrix Corporation's new Lipoprint(TM) System, the only test that measures how much cholesterol is in each LDL (bad) sub-fraction. The FDA approval of this new test, which gives physicians more specific data about a patient's LDL sub-fractions (bad cholesterol), came just as recommendations for more cholesterol lowering drug therapy was announced by the NCEP (National Cholesterol Educational Program). more
|
|
Gonorrhea Resistant To Most Drugs In UK
Gonorrhea, one of the most common sexually transmitted diseases in the UK, is building up resistance to the drugs designed to treat it. A report by the Public Health Laboratory Service (PHLS) shows that the bacteria that cause the disease is becoming increasingly resistant to antibiotic treatments. The PHLS set up a scheme to monitor levels of resistance in England and Wales. more
|
|
|
